The oral gold compound auranofin triggers arachidonate release and cyclooxygenase metabolism in the alveolar macrophage.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Prostaglandins

• Publication date

  1988-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0090-6980(88)90055-XPMID 3244832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion.

  1988cited by this paper
• An open study of auranofin in the treatment of steroid-dependent asthma.

  1988cited by this paper
• The importance of arachidonate metabolism by immune and nonimmune cells.

  1988cited by this paper
• Hydrogen-peroxide-induced arachidonic acid metabolism in the rat alveolar macrophage.

  1988cited by this paper
• Alveolar macrophage gold retention in rheumatoid arthritis.

  1987cited by this paper
• Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.

  1987cited by this paper
• Effect of auranofin and other gold complexes on the activity of phospholipase C.

  1987cited by this paper
• The cellular pharmacology of auranofin.

  1987cited by this paper
• Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages.

  1987cited by this paper
• Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.

  1987cited by this paper
• Copper modulation of macrophage cyclooxygenase metabolite synthesis.

  1987cited by this paper
• The alveolar macrophage.

  1986cited by this paper
• Effects of gold compounds on leukotriene B4, leukotriene C4 and prostaglandin E2 production by polymorphonuclear leukocytes.

  1986cited by this paper
• Analysis of 6-keto PGF1 alpha, 5-HETE, and LTC4 in rat lung: comparison of GM/MS, RIA, and EIA.

  1986cited by this paper
• Analysis of 6-Keto PGF1a, 5-hete and LTC4 in rat lung: Comparison of GC/MS, RIA, nad EIA

  1986cited by this paper
• Gold exacerbates adjuvant arthritis in the rat.

  1984cited by this paper
• Glucocorticoid inhibition of zymosan-induced arachidonic acid release by rat alveolar macrophages.

  1984cited by this paper
• Remission-inducing therapy in rheumatoid arthritis.

  1983cited by this paper
• Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. Activation by adenosine 5'-triphosphate.

  1983cited by this paper
• In vitro effects of mercury on platelet aggregation, thromboxane and vascular prostacyclin production.

  1983cited by this paper
• Arachidonic acid metabolism and macrophage activation.

  1983cited by this paper
• Stimulation of phospholipid hydrolysis and cell death by mercuric chloride: evidence for mercuric ion acting as a calcium-mimetic agent.

  1983cited by this paper
• Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.

  1982cited by this paper
• Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP.

  1982cited by this paper
• How is the level of free arachidonic acid controlled in mammalian cells?

  1982cited by this paper
• Acrolein: a potent modulator of lung macrophage arachidonic acid metabolism.

  1982cited by this paper
• Arachidonic acid metabolism as a source of inflammatory mediators and its inhibition as a mechanism of action for anti-inflammatory drugs

  1981cited by this paper
• The role of macrophage secretory products in chronic inflammatory processes.

  1980cited by this paper
• Alterations in human monocyte structure and function induced by incubation with gold sodium thiomalate.

  1979cited by this paper
• Gold salt in the treatment of bronchial asthma--a double-blind study.

  1978cited by this paper
• RELEASE OF MEDIATORS OF ANAPHYLAXIS: INHIBITION OF PROSTAGLANDIN SYNTHESIS AND THE MODIFICATION OF RELEASE OF SLOW REACTING SUBSTANCE OF ANAPHYLAXIS AND HISTAMINE

  1978cited by this paper
• Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.

  1977cited by this paper
• Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme.

  1977cited by this paper
• Diffuse pulmonary injury associated with gold treatment.

  1976cited by this paper
• Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients.

  1976cited by this paper
• Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles.

  1972cited by this paper
• Prostaglandins.

  1968cited by this paper
• The alveolar macrophage

  1960cited by this paper
• December

  1855cited by this paper

• Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin

  2013cites this paper
• An evaluation of the anti-inflammatory activity and mechanism of action of three novel auranofin derivatives

  2009cites this paper
• Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages

  2008cites this paper
• [Analysis of the mechanism for the anti-inflammatory effect of the anti-rheumatic drug auranofin].

  2000cites this paper
• Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes.

  1999cites this paper
• Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages.

  1997cites this paper
• Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins.

  1997cites this paper
• Dual effects of auranofin on prostaglandin E2 production by rat peritoneal macrophages.

  1997cites this paper
• The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines.

  1997cites this paper
• Auranofin inhibits the induction of interleukin 1β and tumor necrosis factor α mRNA in macrophages

  1995cites this paper
• Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages.

  1995cites this paper
• Antirheumatic gold compounds and penicillamine enhance protein kinase C‐mediated activation of the arachidonate‐ mobilizing phospholipase A2 in mouse macrophages

  1993cites this paper
• Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.

  1990cites this paper